CCMG
TMO icon

Clark Capital Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Clark Capital Management Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Sell
4,276
-114
-3% -$61.9K 0.01% 271
2025
Q4 		$2.54M Buy
4,390
+255
+6% +$144K 0.02% 246
2025
Q3 		$2.01M Buy
4,135
+15
+0.4% +$6.98K 0.01% 261
2025
Q2 		$1.67M Sell
4,120
-355
-8% -$148K 0.01% 275
2025
Q1 		$2.23M Buy
4,475
+30
+0.7% +$16.2K 0.02% 252
2024
Q4 		$2.31M Buy
4,445
+23
+0.5% +$12.6K 0.02% 249
2024
Q3 		$2.74M Sell
4,422
-114
-3% -$67.5K 0.02% 230
2024
Q2 		$2.51M Buy
4,536
+281
+7% +$161K 0.02% 221
2024
Q1 		$2.47M Sell
4,255
-194
-4% -$109K 0.02% 232
2023
Q4 		$2.36M Sell
4,449
-60,668
-93% -$29.4M 0.02% 220
2023
Q3 		$33M Buy
65,117
+1,090
+2% +$581K 0.33% 99
2023
Q2 		$33.4M Sell
64,027
-10,442
-14% -$5.63M 0.3% 100
2023
Q1 		$42.9M Sell
74,469
-58,736
-44% -$33.1M 0.48% 63
2022
Q4 		$73.4M Buy
133,205
+38,520
+41% +$20.4M 0.67% 22
2022
Q3 		$48M Buy
94,685
+56,016
+145% +$31.3M 0.63% 32
2022
Q2 		$21M Buy
38,669
+35,434
+1,095% +$19.5M 0.28% 122
2022
Q1 		$1.91M Sell
3,235
-422
-12% -$242K 0.02% 239
2021
Q4 		$2.44M Sell
3,657
-24,217
-87% -$15.1M 0.03% 210
2021
Q3 		$15.9M Buy
27,874
+24,838
+818% +$13.6M 0.22% 150
2021
Q2 		$1.53M Sell
3,036
-602
-17% -$284K 0.02% 248
2021
Q1 		$1.66M Buy
3,638
+83
+2% +$39.6K 0.03% 232
2020
Q4 		$1.66M Sell
3,555
-42
-1% -$19.7K 0.03% 239
2020
Q3 		$1.59M Sell
3,597
-74
-2% -$30.6K 0.03% 226
2020
Q2 		$1.33M Sell
3,671
-117
-3% -$39.2K 0.02% 215
2020
Q1 		$1.07M Sell
3,788
-288
-7% -$90.8K 0.03% 204
2019
Q4 		$1.32M Sell
4,076
-469
-10% -$142K 0.03% 209
2019
Q3 		$1.32M Sell
4,545
-101
-2% -$28.9K 0.03% 204
2019
Q2 		$1.36M Buy
4,646
+622
+15% +$171K 0.03% 199
2019
Q1 		$1.1M Buy
4,024
+19
+0.5% +$4.73K 0.03% 206
2018
Q4 		$896K Buy
4,005
+115
+3% +$27K 0.02% 201
2018
Q3 		$949K Buy
3,890
+226
+6% +$52K 0.02% 200
2018
Q2 		$759K Sell
3,664
-432
-11% -$91.7K 0.02% 204
2018
Q1 		$846K Buy
4,096
+717
+21% +$150K 0.03% 209
2017
Q4 		$642K Sell
3,379
-3,021
-47% -$579K 0.02% 223
2017
Q3 		$1.21M Buy
6,400
+3,285
+105% +$595K 0.04% 204
2017
Q2 		$543K Buy
3,115
+156
+5% +$26.2K 0.02% 223
2017
Q1 		$454K Sell
2,959
-33,842
-92% -$5.17M 0.02% 235
2016
Q4 		$5.19M Buy
36,801
+33,019
+873% +$4.87M 0.27% 109
2016
Q3 		$602K Sell
3,782
-4,333
-53% -$668K 0.03% 235
2016
Q2 		$1.2M Buy
8,115
+3,818
+89% +$564K 0.08% 185
2016
Q1 		$608K Sell
4,297
-1
-0% -$134 0.05% 205
2015
Q4 		$610K Buy
4,298
+1
+0% +$133 0.05% 193
2015
Q3 		$525K Hold
4,297
– – 0.05% 208
2015
Q2 		$558K Hold
4,297
– – 0.05% 208
2015
Q1 		$577K Sell
4,297
-89
-2% -$11.5K 0.05% 209
2014
Q4 		$550K Sell
4,386
-274
-6% -$33.3K 0.05% 189
2014
Q3 		$567K Sell
4,660
-515
-10% -$62.6K 0.05% 180
2014
Q2 		$611K Sell
5,175
-60
-1% -$7.06K 0.05% 169
2014
Q1 		$629K Sell
5,235
-12
-0.2% -$1.43K 0.05% 168
2013
Q4 		$584K Sell
5,247
-18
-0.3% -$1.79K 0.05% 165
2013
Q3 		$485K Sell
5,265
-1,174
-18% -$106K 0.04% 184
2013
Q2 		$545K Buy
+6,439
New +$536K 0.05% 172

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clark Capital Management Group's TMO Position: Q1 2026 in Review

Clark Capital Management Group reduced its Thermo Fisher Scientific (TMO) stake by 2.6% in Q1 2026, selling an estimated $61.9K and leaving 4,276 shares worth $2.1M. The position accounts for 0.01% of the portfolio, ranked #271.

Clark Capital Management Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $73.4M in Q4 2022. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Clark Capital Management Group held 4,276 shares of Thermo Fisher Scientific worth $2.1M as of Q1 2026.
  • Clark Capital Management Group sold 114 Thermo Fisher Scientific shares in Q1 2026, an estimated $61.9K.
  • Thermo Fisher Scientific made up 0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #271 holding.
  • Clark Capital Management Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Clark Capital Management Group's Thermo Fisher Scientific position peaked at $73.4M in Q4 2022.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.